SmallCap 60: Ortho Regenerative (ORTH: CSE) (ORTIF: OTCQB) Receives $500,000 Grant From Axelys, To Advance Development of ORTHO-M For #MeniscusRepair
posted on
Jun 27, 2022 06:00PM
Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute